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Mutations in a 443-bp amplicon of the hypervariable region
HVR1 of the D-loop of mitochondrial DNA (mtDNA) were
quantified in DNA extracted from peripheral blood samples
of 10 retired radiation workers who had accumulated external
radiation doses of .0.9 Sv over the course of their working
life and were compared to the levels of mutations in 10 control
individuals matched for age and smoking status. The mutation
rate in the 10 exposed individuals was 9.92 3 1025 mutations/
nucleotide, and for the controls it was 8.65 3 1025 mutations/
nucleotide, with a procedural error rate of 2.65 3 1025 mu-
tations/nucleotide. No increase in mtDNA mutations due to
radiation exposure was detectable (P 5 0.640). In contrast,
chromosomal translocation frequencies, a validated radiobi-
ological technique for retrospective dosimetric purposes, were
significantly elevated in the exposed individuals. This suggests
that mutations identified through sequencing of mtDNA in
peripheral blood lymphocytes do not represent a promising
genetic marker of DNA damage after low-dose or low-dose-
rate exposures to ionizing radiation. There was an increase in
singleton mutations above that attributable to procedural er-
ror in both exposed and control groups that is likely to reflect
age-related somatic mutation. q 2006 by Radiation Research Society
INTRODUCTION
In addition to the nuclear genome, each human cell con-
tains thousands of copies of a 16.5-kbp circular molecule
of double-stranded DNA located in the mitochondria. This
extrachromosomal genome codes for a small number of
proteins involved in the respiratory chain (13 protein-cod-
ing genes) as well as two ribosomal RNA subunits and 22
tRNA genes. In addition, each mtDNA copy contains a
1 Address for correspondence: Genetics Department, Westlakes Re-
search Institute, Moor Row, Cumbria, CA24 3JY, United Kingdom;
e-mail: craig.wilding@westlakes.ac.uk.
short sequence, the D loop, involved in transcription and
replication of mtDNA. Inherited defects in mtDNA may
result in mitochondrial dysfunction that can contribute to
degenerative disease (1–3). Such defects can affect all cop-
ies of the mtDNA within a cell (termed homoplasmy), or
there may be a mixture of mutated and wild-type mtDNA
copies (heteroplasmy). Due to the multi-copy nature of the
mtDNA, with multiple mtDNA per mitochondrion and
many mitochondria per cell, when defects exist in hetero-
plasmic form, a threshold value of mutant types must be
surpassed before mutations cause a biochemical defect of
the respiratory chain (4).
The mitochondrial genome is characterized by a higher
spontaneous mutation rate than the nuclear genome (5).
This is thought to be due to the absence of histones pro-
tecting the coiled DNA as well as the immense oxygen
metabolism and presence of reactive oxygen species in the
mitochondrion. In addition, the mitochondrion has an un-
derdeveloped DNA repair repertoire compared with the nu-
clear genome (6). As a consequence, in addition to inher-
ited mutations, sporadic somatic mutations can occur. Nu-
merous point mutations and insertion or deletion of se-
quence (indels) have been characterized in mtDNA (6).
Such sporadic mutations have been seen to accumulate with
age in various tissues (7).
The tendency for cells to accumulate mtDNA mutations
suggests that mtDNA might be a useful biomarker of ra-
diation exposure. MtDNA is susceptible to genotoxic dam-
age including that induced by exposure to g radiation (8)
and X radiation which has been shown to damage isolated
mtDNA and cellular mtDNA in a dose-dependent manner
(9). The frequency of the common deletion, a species of
mtDNA with a 4977-bp deletion, has also been seen to
increase in irradiated cell lines (10). This has led to the
suggestion that the common deletion may prove useful in
retrospective biological dosimetry (11). However, when the
incidence of the common deletion was measured in indi-
viduals exposed by virtue of atomic weapons testing at
Semipalatinsk, Kazakhstan and compared to unexposed
populations there was no difference in frequency (12).
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Exp1 73 LXS 1.329
Exp2 72 N 1.143
Exp3 77 N 1.109
Exp4 68 HXS 1.015
Exp5 68 LS 0.946
Exp6 78 N 1.204
Exp7 79 HS 0.986
Exp8 76 LXS 1.873
Exp9 80 N 1.161
Exp10 67 N 0.920
Mean 73 1.169
C1 72 LXS 0.004
C2 71 N 0
C3 80 N 0.018
C4 68 HXS 0
C5 69 LXS 0.003
C6 73 N 0.006
C7 76 HXS 0.006
C8 74 LXS 0.016
C9 77 N 0
C10 69 N 0
Mean 72 0.005
a Experimental samples (Exp1–Exp10) and control samples (C1–C10).
b N 5 never smoker, LXS 5 low ex-smoker, HXS 5 high ex-smoker,
LS 5 low smoker, HS 5 high smoker.
While we recognize that ionizing radiation is known to
be capable of inducing large-scale DNA deletions in the
nuclear DNA (13), and deletions are inducible in mtDNA,
radiation exposure is also associated with the introduction
of point mutations (14). It is point mutations that are the
target of the present study. mtDNA point mutations have
been reported after acute in vivo exposure to high doses of
ionizing radiation in individuals undergoing radiotherapy
(15), and an increase in such mutations has been seen after
chronic exposures to much lower dose rates of ionizing
radiation in families inhabiting naturally radioactive areas
(16). Since most copies of mtDNA carrying deletions are
lost from circulating blood cells (17) while neutral point
mutations appear not to be selected against, mtDNA point
mutation frequencies rather than levels of large-scale de-
letions, such as the common deletion, may be a suitably
sensitive biomarker of exposure to low doses of ionizing
radiation such as those experienced in an occupational set-
ting.
Selection appears to be weaker on mutations arising in
non-coding regions of mtDNA (18), and consequently it is
preferential to study such regions when quantifying muta-
tion accumulation. The non-coding D-loop of the mtDNA
has been shown previously to accumulate point mutations
in studies of aging individuals (7, 19) and of those exposed
to radiation (15). Here we examine the frequency of point
mutations within the hypervariable region 1 (HVR1) of the
mitochondrial DNA in a group of retired radiation workers
exposed occupationally to ionizing radiation and compare
them to point mutations in unexposed controls.
MATERIALS AND METHODS
Samples
All participants were retired employees of the British Nuclear Fuel Ltd
(BNFL) Sellafield nuclear fuel facility. Samples were taken from 10 in-
dividuals who had received cumulative external radiation doses .0.9 Sv
measured through film badge monitoring (20). Exposures occurred over
a period of 20–37 years and were within the permitted limits operating
at the time. Ten individuals who had received doses ,0.02 Sv and who
were matched for age and smoking status provided control samples. All
participants were British Caucasians. Details of participants are given in
Table 1.
Approval for the study was given by the West Cumbria Local Research
Ethics Committee.
Molecular Methods
DNA was extracted from peripheral blood lymphocytes according to
standard methods and standardized to 100 ng/ml. A 443-bp fragment of
the HVR1 region of mtDNA was amplified with the primers L15995 (59-
CCA CCA TTA GCA CCC AAA G-39) and H16401 (59-GAT TTC ACG
GAG GAT GGT G-39). To minimize PCR-generated mutations, we used
the thermostable proofreading polymerase PfUUltra, which has an ex-
tremely high fidelity (21, 22). PCR mixes contained 13 PCR buffer, 200
mM dNTPs, 25 pmol of each primer, 100 ng DNA, and 2.5 U PfUUltra
DNA polymerase (Stratagene). Amplification was undertaken on a
PE9700 thermal cycler with conditions of 948C for 2 min, followed by
30 cycles of 948C for 1 min, 528C for 1 min, and 728C for 1 min with
a final extension time of 8 min. PCR products were purified using the
StrataPrept PCR purification kit (Stratagene) according to the manufac-
turer’s instructions.
Purified PCR products were cloned into PCR-scripty Amp-SK(1)
(Stratagene) and transformed into XL-10-Goldt. Recombinant plasmids
were identified by blue-white color selection. After overnight growth of
white colonies in 3 ml LB broth, plasmids were purified with a QIAprept
Spin Miniprep kit. Inserts were screened by agarose gel electrophoresis
after HindIII-SacI digestion. The fidelity of the assay was determined
through sequencing of plasmids derived from amplification of a single
clone. Plasmids from this experiment were standardized to 100 ng/ml and
were then sequenced on a Beckman Coulter CEQ8000 with Quickstart
sequencing reagents. Plasmid DNA containing inserts derived from ex-
perimental samples was standardized to a concentration of 100 ng/ml and
then sent for commercial sequencing (MWG-Biotech).
Sequence Analysis
Sequences were aligned against the revised Cambridge reference se-
quence (CRS) (23, 24) using ClustalX (25). The 405 bp of sequence
between positions 15996–16400 was successfully read from each copy.
Discrepant positions were verified through manual comparison with the
electropherogram.
Heteroplasmies were defined as mutations found in more than one
clone of a single individual, and these were not included for the deter-
mination of mutation rate. This is a more conservative methodology than
that applied by Simon et al. (26), who excluded only those mutations in
fewer than three clones. Excluded mutations are listed but were not used
in our estimation of mutation rate. Indels involving $2 bp were treated
as a single event. Mutation rate was calculated as number of mutations/
(number of clones sequenced 3 405), where the length of the insert DNA
without primers is 405 bp. Mutation levels in high-dose individuals and
in controls were compared using Fisher’s exact test.
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RESULTS
Procedural Error Rate
Plasmid DNA from a single clone containing a PCR
product (443 bp) of the HVR1 region of the mtDNA was
used as template for PCR and the amplification product was
cloned. Of 93 full-length clones sequenced, only one con-
tained a mutation (T16301C). This suggests a procedural
error rate of 2.65 3 1025 mutations/nucleotide (1/93 3 405
bp).
Sample Analysis
DNA isolated from peripheral blood samples was used
as templates for amplification of a 443-bp section of the
HVR1 region that was subsequently cloned. Up to 100 sep-
arate cloned amplicons were then sequenced. A small frac-
tion of clones exhibited sequences with multiple substitu-
tions (.30% sequence divergence) and numerous indel
events. These displayed hallmarks of pseudogenic sequenc-
es and were discounted from further analysis. Nuclear pseu-
dogene copies of mtDNA genes are recognized (27), and
amplification of mitochondrial control region pseudogene
sequences is recognized as a problem when PCR is under-
taken on DNA isolated from blood samples (28).
Each of the 20 samples differed in homoplasmic se-
quence from the CRS by between 0–8 bp (Table 2). Each
sample also exhibited mutations in individual mtDNA cop-
ies. Where two or more identical mutant copies were seen,
these were counted not as two (or more) identical singleton
substitutions but as a heteroplasmy (Table 2). Multiple het-
eroplasmy was identified in individual C4, with three dif-
ferent mtDNA types encountered (disregarding singleton
substitutions). These were within the 16184–16193 poly-C
tract known to be unstable during replication, which results
in multiple poly-C tract length variants (29).
Singleton substitutions were seen in between one and
eight of the clones examined from each individual (Table
2). While more substitutions were observed in the exposed
samples, no significant increase in mutation rate was de-
tected. The overall mutation rate based on singleton sub-
stitutions within the exposed samples was 9.92 3 1025 mu-
tations/nucleotide, and for the control samples it was 8.65
3 1025 mutations/nucleotide. This is not significantly dif-
ferent (P 5 0.640). Mutations identified by the sequencing
were point mutations, deletions or insertions, with 70.6%
transitions, 20.6% transversions, and 8.8% indels in the
controls and 82.1% transitions, 10.3% transversions, and
7.7% indels in the exposed samples.
DISCUSSION
We have addressed the question of whether low doses of
radiation received in an occupational setting resulted in a
significant increase in mutations in the HVR1 region of
mitochondrial DNA detected through cloning and sequenc-
ing of PCR amplicons. Gamma radiation produces a similar
mutational spectrum to that resulting from oxidative dam-
age (30), including mainly base substitutions, predomi-
nantly GC→AT transitions followed by GC→TA transver-
sions, but also indels (30). The types of mutations identified
in this study agree favorably with those expected of
mtDNA, i.e. 80% transitions and 6% indels (6), although
the control samples exhibited fewer transitions and more
transversions. Although point mutations were detected, we
found no increase in mutation levels when individuals ex-
posed to up to 1.873 Sv (mean 1.169 Sv), in small frac-
tionated doses over the working life of the individual, were
compared to control individuals matched for age and smok-
ing status and employed at the same nuclear facility who
received less than 0.02 Sv radiation (mean 0.005 Sv).
Chromosomal translocations, a recognized and validated
biomarker of exposure to ionizing radiation (31), have been
measured previously in these individuals (32). When trans-
location frequencies are compared between these same in-
dividuals, there is a statistically significant difference that
is attributable to radiation exposure (control group trans-
location frequency 5 17.41 6 2.25 3 1023 per genome
equivalent; exposed group translocation frequency 5 28.41
6 2.87 3 1023 per genome equivalent; P 5 0.041). This
indicates that mtDNA is not as sensitive a biomarker of
cumulative radiation exposure as the measurement of trans-
location frequencies.
DNA for this study was extracted from circulating pe-
ripheral blood lymphocytes, and it has been suggested that
due to the high turnover of blood, accumulation of mtDNA
mutations may be inhibited (17). However, since the cu-
mulative exposures of the high-dose group were acquired
over the total working life of the individuals, it is the ex-
posure of the hematopoietic stem cells that is important,
since circulating lymphocytes are short lived and could
therefore provide information only on recent exposures.
Mutations in the mtDNA have been demonstrated to ac-
cumulate in colonic stem cells (33), and we would therefore
expect that if fractionated exposure to low doses of radia-
tion did result in significant increases in mtDNA mutations,
they would be demonstrable in the descendant lymphocytes
with this assay. However, the individuals studied here
ceased employment at the Sellafield nuclear facility 10–26
years previously, and thus it is possible that mtDNA mu-
tations are not sufficiently persistent and that although
mtDNA mutations were induced by exposure, the mutations
acquired were subsequently lost. Although mtDNA muta-
tions are recognized to accumulate with age (7, 19) and
mutations within the D-loop are not believed to be under
strong selection pressure (18), persistence of mutations has
not been tested adequately. While chromosomal transloca-
tions are a stable biomarker of radiation exposure of he-
matopoietic stem cells (34), the kinetics of mitochondrial
replication is radically different from that of the nuclear
DNA (1), and the long-term persistence of mtDNA muta-
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compared to CRSb Heteroplasmyc Singleton substitutionsd
C1 100 A16235G, C16261T, C16291T,
C16292T
No C16021G, G16034A, C16057T,
C16107T, T16292C*,
G16329&T16330 del§, G16336 del,
C16355T
C2 96 C16069T, T16126C, G16145A,
T16231C, C16261T
A16302G (11) G16039A, G16047T, A16212T,
C16188T, T16189C, C16348T
C3 98 C16261T, A16293G, T16311C No G16153A
C4 96 N/A No C16111T, T16131G, C16191T
C5 94 A16293G, T16311C No A16081G, A16180G
C6 97 T16263C No A16181C, C16258ins
C7 97 T16224C, T16311C T16093C (6) T16008C, C16056T, C16256T
C8 97 T16092C, T16140C, A16293G,
T16311C
C16092T (3)* A16305G, C16375T
C9 98 N/A No T16136A
C10 97 T16297C No G16084A, T16172C†, A16269G†,
C16270T, C16291T, C16393A
Exp1 100 C16301T, A16343G, T16356C,
G16390A
No A16220G, A16317G, A16383G
Exp2 97 N/A No G16000A†, T16093C, T16093G,
C16095T, C16328T, T16347C,
G16390A†
Exp3 98 C16286T No C16107T, A16162 del, G16244A,
T16311C
Exp4 96 T16189C G ins‡ (13) GG ins‡ (10)
T16189 del (11)
A16180 del, A16183C
Exp5 96 No No G16049T, A16146G, T16172C,
C16365T
Exp6 97 T16093C, C16221T, C16266T,
A16399G
C16093T (46) T16020C, C16114T, A16207G
Exp7 97 G16129A, C16223T, G16391A No G16039 del, C16111T†, T16124C,
G16125A, C16256T†
Exp8 97 C16069T, T16126C No G16129A†, C16176T, A16258T,
C16287T, G16346A†
Exp9 96 T16093C, C16192T, A16207G,
C16256T, C16270T, C16291T,
T16324C, A16399G
C16093T (5)* T16029C, T16192C*
Exp10 96 T16093C, T16224C, T16311C,
G16319A
C16093T (10)* A16293G, A16343G, G16390A,
G16391A
a No. clones sequenced 5 numbers of full-length clones successfully sequenced.
b Homoplasmic base changes are given relative to the position in the Cambridge reference sequence (23, 24).
c Heteroplasmies are given with numbers in parentheses indicating the number of clones displaying the heteroplasmic position (*indicates revision
of sequence to the sequence of the CRS).
d Singleton substitutions are given as positions relative to CRS (23, 24) († 5 substitutions found in same clone, § 5 2-bp deletion counted as single
event). ‡ 5 insertions in the 16184–16193 poly-C tract.
tions after historical exposure to genotoxic agents is un-
known.
The finding that no significant increase in mtDNA mu-
tations results from chronic occupational radiation exposure
contrasts with the increase in mtDNA mutation frequency
seen in patients exposed to therapeutic doses of radiation
compared to nonexposed patients (15). However, the doses
and dose delivery regimens differ markedly. Individuals un-
dergoing radiotherapy in the study of Wardell et al. (15)
were a mixed cancer group who received total doses be-
tween 35–152 Gy (to the target organ) in an acute fashion.
No information is available about the dose received by the
bone marrow and thus the dose received by the hemato-
poietic stem cells. In contrast, the retired radiation workers
for this study received much lower doses in small daily
increments. In a study of individuals inhabiting the area
around Semipalatinsk, a nuclear testing site for the Soviet
Union, no increase in the frequency of the common deletion
was seen in comparison to controls (12). These individuals
would similarly have received their accumulated dose in a
chronic fashion. Since the common deletion is known to be
inducible by ionizing radiation (10), this also suggests that
low-dose radiation received chronically either does not re-
sult in mtDNA mutations (or is efficiently repaired) or that
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the system employed in these studies is not sensitive
enough to detect small increases with the sample sizes
available. It is also interesting to note that studies of native
voles or experimentally enclosed laboratory mice in the vi-
cinity of Chernobyl have failed to detect an increase in
mitochondrial mutations after chronic exposures (35–37).
We are mindful that this study employed only small sam-
ple sizes (although examining a large number of clones per
individual). However, although an increase in sample size
may be appropriate, the methodology employed is time
consuming and expensive and does not lend itself to high
throughput. To extend the sample size in the current study,
it may be that a more appropriate technique for examining
large numbers of clones from large numbers of samples
would involve screening of inserts with denaturing high-
performance liquid chromatography (38).
Although no increase in mutations of the mitochondrial
control region attributable to radiation exposure was de-
tectable, we did see an increase in mitochondrial mutations
in both exposed and control populations that is above the
procedural error rate of the system employed (i.e. mutation
rate in the technical controls). This presumably reflects an
increase in mitochondrial mutations due to age in these in-
dividuals (mean age 73 years, range 67–81, for exposed
samples, and mean age 72 years, range 68–81, for controls).
However, we have no young population with which to com-
pare for the specific examination of age effects. The mu-
tations we detect are, however, individually rare.
There is thus no evidence that occupational exposure to
low doses of radiation results in an increase in mtDNA
mutation rate in hematopoietic stem cells as measured
through the examination of peripheral blood lymphocytes.
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